Nektar Therapeutics

NKTRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.584 B

$76.48 +4.13%

Close of 7 Aug 2026

Revenue

$55.2M

#2708 by revenue

Earnings

-$164.0M

Loss-making

Shares outstanding

28,687,963

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#89Prestige Consumer HealthcarePBH$2.60B
#90PrecigenPGEN$2.59B
#91Nektar TherapeuticsNKTR$2.58B
#92Ultragenyx PharmaceuticalRARE$2.55B
#93Amylyx PharmaceuticalsAMLX$2.54B

Where these numbers come from

Share counts and financials for Nektar Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.